Liu Hui, Zhu Ping
Department of Hematology, Peking University First Hospital, Beijing 100034, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Dec;17(6):1588-91.
There are great differences in the clinical process and prognosis of the chronic lymphocytic leukemia(CLL), the precise diagnosis is of importance to judge prognosis, guide therapy and research pathogenesis mechanism. The variable region mutation of immunoglobulin heavy chain is the most stable molecular index of disease prediction. The patients with sequence of IgHV somatic high mutation usually have a better prognosis and a more longer survival time than those without the mutation. The recent study has found that specific IgHV gene expression also can predict the disease outcome in some cases regardless of mutation. The clinical prognosis of CLL patients can be further stratified by specific IgHV gene expression. In this review, the progress in the research of the clinical significance of specific IgHV gene expression in the chronic lymphocytic leukemia is summarized.
慢性淋巴细胞白血病(CLL)的临床进程和预后存在很大差异,准确诊断对于判断预后、指导治疗及研究发病机制至关重要。免疫球蛋白重链可变区突变是疾病预测中最稳定的分子指标。与未发生突变的患者相比,具有IgHV体细胞高突变序列的患者通常预后较好,生存时间更长。最近的研究发现,特定的IgHV基因表达在某些情况下也可以预测疾病结局,而不考虑突变情况。CLL患者的临床预后可通过特定的IgHV基因表达进一步分层。本文综述了慢性淋巴细胞白血病中特定IgHV基因表达临床意义的研究进展。